Longping V. Tse

10.9k total citations · 1 hit paper
29 papers, 1.5k citations indexed

About

Longping V. Tse is a scholar working on Infectious Diseases, Genetics and Molecular Biology. According to data from OpenAlex, Longping V. Tse has authored 29 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 13 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Longping V. Tse's work include Virus-based gene therapy research (12 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and CRISPR and Genetic Engineering (7 papers). Longping V. Tse is often cited by papers focused on Virus-based gene therapy research (12 papers), SARS-CoV-2 and COVID-19 Research (7 papers) and CRISPR and Genetic Engineering (7 papers). Longping V. Tse collaborates with scholars based in United States, Spain and Germany. Longping V. Tse's co-authors include Ralph S. Baric, Gary R. Whittaker, Aravind Asokan, Timothy P. Sheahan, Rita M. Meganck, Weishan Huang, L. Patrick Havlik, J. Kennon Smith, Mavis Agbandje‐McKenna and Victoria J. Madigan and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Longping V. Tse

29 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells

2021 203 citations Shuntai Zhou, Collin S Hill et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Longping V. Tse United States	18	728	551	427	291	184	29	1.5k
Ande West United States	17	1.0k 1.4×	790 1.4×	248 0.6×	233 0.8×	193 1.0×	28	2.0k
Lizhou Zhang China	16	936 1.3×	421 0.8×	113 0.3×	278 1.0×	207 1.1×	42	1.5k
J. Craig Forrest United States	24	1.1k 1.5×	525 1.0×	739 1.7×	625 2.1×	243 1.3×	47	2.2k
Sarah A. Kopecky-Bromberg United States	7	973 1.3×	239 0.4×	167 0.4×	128 0.4×	343 1.9×	8	1.3k
Christel Schwegmann‐Weßels Germany	22	956 1.3×	191 0.3×	292 0.7×	297 1.0×	576 3.1×	30	1.3k
Thomas Gallagher United States	20	1.2k 1.7×	307 0.6×	249 0.6×	194 0.7×	856 4.7×	26	1.7k
Marne C. Hagemeijer Netherlands	12	628 0.9×	359 0.7×	104 0.2×	167 0.6×	260 1.4×	20	1.1k
Ofir Israeli Israel	13	350 0.5×	600 1.1×	111 0.3×	333 1.1×	65 0.4×	52	1.1k
Denis Y. Logunov Russia	21	315 0.4×	455 0.8×	273 0.6×	344 1.2×	45 0.2×	141	1.5k
Blandine Monel France	12	603 0.8×	408 0.7×	101 0.2×	137 0.5×	81 0.4×	14	1.1k

Countries citing papers authored by Longping V. Tse

Since Specialization

Citations

This map shows the geographic impact of Longping V. Tse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longping V. Tse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longping V. Tse more than expected).

Fields of papers citing papers by Longping V. Tse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longping V. Tse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longping V. Tse. The network helps show where Longping V. Tse may publish in the future.

Co-authorship network of co-authors of Longping V. Tse

This figure shows the co-authorship network connecting the top 25 collaborators of Longping V. Tse. A scholar is included among the top collaborators of Longping V. Tse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longping V. Tse. Longping V. Tse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tse, Longping V., Yixuan J. Hou, Rhianna E. Lee, et al.. (2023). A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus. Science Translational Medicine. 15(715). eadg5567–eadg5567. 10 indexed citations

Meganck, Rita M., et al.. (2023). Evolution of a functionally intact but antigenically distinct DENV fusion loop. eLife. 12. 1 indexed citations

Thijssen, Marijn, Yanjuan Xu, Longping V. Tse, et al.. (2023). Expansion of Betatorquevirus and/or Gammatorquevirus in Patients with Severe Clinical Outcomes of the Liver Diseases. Viruses. 15(8). 1635–1635. 3 indexed citations

Munt, Jennifer E., Ellen Young, Yixuan J. Hou, et al.. (2023). Homotypic antibodies target novel E glycoprotein domains after natural DENV 3 infection/vaccination. Cell Host & Microbe. 31(11). 1850–1865.e5. 6 indexed citations

Meganck, Rita M., et al.. (2023). Evolution of a functionally intact but antigenically distinct DENV fusion loop. eLife. 12. 2 indexed citations

Young, Ellen, Boyd L. Yount, Petraleigh Pantoja, et al.. (2023). A live dengue virus vaccine carrying a chimeric envelope glycoprotein elicits dual DENV2-DENV4 serotype-specific immunity. Nature Communications. 14(1). 1371–1371. 11 indexed citations

Stanifer, Megan L., Sarah R. Leist, Bettina Stolp, et al.. (2022). Ex vivo and in vivo suppression of SARS-CoV-2 with combinatorial AAV/RNAi expression vectors. Molecular Therapy. 30(5). 2005–2023. 14 indexed citations

Zhou, Shuntai, Collin S Hill, Sanjay Sarkar, et al.. (2021). β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells. The Journal of Infectious Diseases. 224(3). 415–419. 203 indexed citations breakdown →

Tse, Longping V., Rita M. Meganck, Rachel L. Graham, & Ralph S. Baric. (2020). The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses. Frontiers in Microbiology. 11. 658–658. 71 indexed citations

10.

Leist, Sarah R., Kenneth H. Dinnon, Alexandra Schäfer, et al.. (2020). A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory Mice. Cell. 183(4). 1070–1085.e12. 332 indexed citations

11.

Madigan, Victoria J., Anna M. Chiarella, Rita M. Meganck, et al.. (2019). Ring finger protein 121 is a potent regulator of adeno-associated viral genome transcription. PLoS Pathogens. 15(8). e1007988–e1007988. 23 indexed citations

12.

McGee, Michael C., Longping V. Tse, Chengwen Li, et al.. (2019). Adeno-associated viral vector-mediated immune responses: Understanding barriers to gene delivery. Pharmacology & Therapeutics. 207. 107453–107453. 126 indexed citations

13.

Tse, Longping V., Victoria J. Madigan, Ruth M. Castellanos Rivera, et al.. (2017). Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion. Proceedings of the National Academy of Sciences. 114(24). E4812–E4821. 166 indexed citations

14.

Berry, Garrett E. & Longping V. Tse. (2017). Virus Binding and Internalization Assay for Adeno-associated Virus. BIO-PROTOCOL. 7(2). 19 indexed citations

15.

Tse, Longping V. & Gary R. Whittaker. (2015). Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase. Virology. 482. 1–8. 14 indexed citations

16.

Tse, Longping V., Sven Møller-Tank, & Aravind Asokan. (2015). Strategies to circumvent humoral immunity to adeno-associated viral vectors. Expert Opinion on Biological Therapy. 15(6). 845–855. 50 indexed citations

17.

Tse, Longping V., Yueting Zhang, & Gary R. Whittaker. (2013). Immunoplaque Assay (Influenza Virus). BIO-PROTOCOL. 3(21). 1 indexed citations

18.

Regan, Andrew D., Jean K. Millet, Longping V. Tse, et al.. (2012). Characterization of a recombinant canine coronavirus with a distinct receptor-binding (S1) domain. Virology. 430(2). 90–99. 39 indexed citations

19.

Guo, Huatao, et al.. (2011). Target Site Recognition by a Diversity-Generating Retroelement. PLoS Genetics. 7(12). e1002414–e1002414. 23 indexed citations

20.

Guo, Huatao, Longping V. Tse, Roman Barbalat, et al.. (2008). Diversity-Generating Retroelement Homing Regenerates Target Sequences for Repeated Rounds of Codon Rewriting and Protein Diversification. Molecular Cell. 31(6). 813–823. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact